The Latest Cardiac and Vascular News
SHANGHAI and PRINCETON, N.J., April 07, 2022 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced the appointment of Wei Wei Chen to the company’s Board of Directors. “I am pleased to welcome Wei […]
PARIS, FRANCE / ACCESSWIRE / April 7, 2022 / Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive solution for the treatment of heart failure patients with pulmonary hypertension, announced today the appointment of Martin Grasse as Chief Executive Officer. With over 15 years in the medical device industry, […]
Investment to Support Company’s Engagement with Health Plans and Self-Insured Employers to Provide Tech-Enabled Value-Based Cardiology Solutions AUSTIN, Texas and ALBUQUERQUE, N.M., April 6, 2022 /PRNewswire/ — Karoo Health, a leader in tech-enabled value-based cardiovascular care solutions, today announced it closed a significant seed funding round. The investment will allow Karoo Health to bring its […]
FORT WORTH, Texas, April 06, 2022 (GLOBE NEWSWIRE) — World-renowned cardiologist Timothy D. Henry, MD, FACC, MSCAI, has joined Flow Therapy’s Board of Directors. Dr. Henry is the Lindner Family Distinguished Chair in Clinical Research and Medical Director of The Carl and Edyth Lindner Center for Research at The Christ Hospital […]
HANOVER, Germany–(BUSINESS WIRE)–Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the appointment of Dr. Russell Greig, as independent Chairman of its Board of Directors. Dr. Greig brings more than 35 years of experience in the pharmaceutical industry from GlaxoSmithKline, with […]
Former GE Healthcare Chief Digital Officer joins group of new leaders spearheading RapidAI’s product innovation; advancing patient care for Pulmonary Embolism, Aneurysm and Stroke globally SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in neurovascular and vascular imaging driving the next evolution of clinical decision making and patient workflow, today announced […]
WASHINGTON, April 4, 2022 /PRNewswire/ — Edward T. A. Fry, MD, FACC, today begins his one-year term as president of the American College of Cardiology, a nonprofit cardiovascular medical society representing over 54,000 cardiologist and cardiovascular care team members around the world. “I am looking forward to learning from and working with ACC’s […]
MENLO PARK, Calif., April 5, 2022 /PRNewswire/ — Endovascular Engineering (“E2”), a privately-held developer of next-generation thrombectomy devices to treat patients with Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), today announced the closing of a $15 million Series A1 financing. The financing was co-led by Santé Ventures and Cordis, who were joined by […]
MONMOUTH JUNCTION, N.J. , April 5, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces the appointment of Ms. Jiny Kim, MBA to CytoSorbents’ Board of Directors as a new independent director, effective immediately, for a term expiring at […]
–Seasoned physician, scientist and life science executive brings expertise in clinical research and development across product life cycle– –Key appointment as Humacyte advances HAV through multiple late-stage clinical trials in initial vascular applications– DURHAM, N.C., April 05, 2022 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company […]
